Literature DB >> 29064468

Neuromuscular disease: Tadalafil fails to halt the progression of Duchenne muscular dystrophy.

Heather Wood.   

Abstract

Entities:  

Year:  2017        PMID： 29064468     DOI： 10.1038/nrneurol.2017.153

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy.

Authors:  Ronald G Victor; H Lee Sweeney; Richard Finkel; Craig M McDonald; Barry Byrne; Michelle Eagle; Nathalie Goemans; Krista Vandenborne; Alberto L Dubrovsky; Haluk Topaloglu; M Carrie Miceli; Pat Furlong; John Landry; Robert Elashoff; David Cox
Journal:  Neurology       Date:  2017-09-29       Impact factor: 9.910
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.